In the current cohort of AIS patients, median fibrinogen level on admission was above 3.5 g/L in both groups of patients (3.88 g/L vs. 3.91 g/L in CBS 0–9 vs. CBS 10), therefore the effect of Leu34 allele could potentially prevail. This evidence concerns the gene CBS and androgen insensitivity syndrome.